Bloomberg TalksBloomberg Talks

Novo Nordisk President and CEO Mike Doustdar Talks Wegovy Pill

View descriptionShare

Bloomberg Talks

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment.
2,476 clip(s)
Loading playlist

Novo Nordisk President & CEO Mike Doustdar discusses the recent US approval of Novo Nordisk's Wegovy weight loss pill, the advantage of being the first to market, the availability of the pill, the company's gameplan, and the timeline of the pill's release. Doustdar spoke with Bloomberg's Katie Greifeld.

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. Bloomberg Talks

    2,476 clip(s)

Bloomberg Talks

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, 
Social links
Follow podcast
Recent clips
Browse 2,475 clip(s)